GH1 and cardiomyopathy: At present, the therapeutic effects of ghrelin on cardiomyopathy are postulated to involve its inhibition of apoptosis of cardiomyocytes, by both GH-IGF-1-dependent [77] and–independent [20, 78, 79] pathways.